US-based Nuvectis Pharma starts human trial on solid tumors
HQ Team September 12, 2023: Nuvectis Pharma, Inc., a US biopharmaceutical firm, has started its experimental trial in humans to treat solid tumors..
Drugs
Health
Pharma